It can increase programmed death-ligand 1 (PD-L1) expression on tumor and immunosuppressive myeloid cells and elevate T-cell immunoreceptors with Ig and ITIM (T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif) domains. This evidence concerns the gene CD274 and neoplasm.